United States· US:0527-1282_2d14aa91-5d9d-42fe-b185-9c3bcd18a513
Dicyclomine Hydrochloride
A dicycloverine product containing dicyclomine hydrochloride, registered in United States by Lannett Company, Inc.. The same ATC class is registered in 3 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dicycloverine is registered in 3 of 19 countries.
Countries holding a registration under ATC A03AA07 (dicycloverine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Dicycloverine · ATC A03AA07
3 / 19 countries
- Canada
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dicycloverine costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- United States: $0.62 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Dicycloverine · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.62 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Dicyclomine Hydrochloride
- Manufacturer
- Lannett Company, Inc.
- Country
- United States (US)
- ATC code
- A03AA07
- ATC class
- Dicycloverine
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 3
- ndc110527128201100 TABLET in 1 BOTTLE (0527-1282-01)
- ndc110527128205500 TABLET in 1 BOTTLE (0527-1282-05)
- ndc1105271282101000 TABLET in 1 BOTTLE (0527-1282-10)
Regulatory notes
Interactions
389 interactions on record for dicycloverine.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dicycloverine · interactions on record
389 records
- 6 severe
- 194 moderate
- 17 minor
- 172 info
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- TopiramatN02CX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dicycloverine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDicycloverine 20mg tabletsSigma Pharmaceuticals Plc
- CanadaJAMP-DICYCLOMINE HCLJAMP PHARMA CORPORATION
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Dicycloverine, Dicycloverine Focus Pharmaceuticals
- Latvia · Trigan-Sp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3035d7b-d823-4045-8d59-406c10c72ea6 GET /v1/drugs/c3035d7b-d823-4045-8d59-406c10c72ea6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "CQ903KQA31",
"rxcui": "152021",
"inchikey": "GUBNMFJOJGDCEL-UHFFFAOYSA-N",
"display_name": "DICYCLOMINE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"spl_meta": {
"bb099db9-f635-4a64-8892-6236971dec45": {
"match": "brand_token",
"title": "DICYCLOMINE HYDROCHLORIDE SOLUTION [PAR HEALTH USA, LLC]",
"spl_version": "8",
"published_date": "2026-05-21"
}
},
"productid": "0527-1282_2d14aa91-5d9d-42fe-b185-9c3bcd18a513",
"productndc": "0527-1282",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "040230",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "20MG",
"product_no": "001",
"approval_date": "Feb 26, 1999"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DICYCLOMINE HYDROCHLORIDE",
"proprietary_name": "Dicyclomine Hydrochloride",
"active_ingred_unit": "mg/1",
"application_number": "ANDA040230",
"marketing_category": "ANDA",
"nonproprietary_name": "Dicyclomine Hydrochloride",
"start_marketing_date": "19990226",
"active_numerator_strength": "20"
}See everything about dicycloverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.